Form 4: Edwards Lifesciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Wayne Markowitz, CVP, JAPAC of Edwards Lifesciences Corp, reported multiple transactions in common stock on September 11, 2026.
Summary
- Tax/exercise-price withholding: disposed of 355 Common Stock at $86.77 ($30,803) on September 11, 2026; holds 19,939 after (Direct).
- Tax/exercise-price withholding: disposed of 568 Common Stock at $84.37 ($47,922) on September 14, 2026; holds 19,371 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Wayne Markowitz — Officer (CVP, JAPAC)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Tax/exercise-price withholding | Common Stock | 355 | $87 | $30.8K | 19,938.558 |
| 2026-09-14 | Tax/exercise-price withholding | Common Stock | 568 | $84 | $47.9K | 19,370.558 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Tax/exercise-price withholding (355 shares) |
| 2026-09-14 | Tax/exercise-price withholding (568 shares) |
Keywords
insider transaction, Form 4, EW, Edwards Lifesciences Corp, neutral, Wayne Markowitz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.